Opes Advisors’s Exact Sciences EXAS Stock Holding History

Opes Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-23,221	Closed	-$1.39M	–	43
2018 Q2	$1.39M	Buy	+23,221	New	+$1.25M	1.02%	24
2017 Q4	–	Sell	-33,221	Closed	-$1.56M	–	45
2017 Q3	$1.56M	Buy	+33,221	New	+$1.34M	1%	25

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Opes Advisors's EXAS Position: Q3 2018 in Review

Opes Advisors sold out of Exact Sciences (EXAS) in Q3 2018, closing a stake of 23,221 shares — an estimated $1.39M sold.

Opes Advisors first reported a position in EXAS in Q3 2017 and held it in 2 quarters. The position peaked at $1.56M in Q3 2017. 365 funds tracked by Wall St. Rank hold EXAS as of Q3 2018.

Opes Advisors reported no remaining Exact Sciences position as of Q3 2018 after selling out during the quarter.
Opes Advisors sold 23,221 Exact Sciences shares in Q3 2018, an estimated $1.39M.
Opes Advisors first reported a position in Exact Sciences in Q3 2017 and held it in 2 quarters.
Opes Advisors's Exact Sciences position peaked at $1.56M in Q3 2017.
365 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2018.

Based on Opes Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.